Metastatic cancer

Common Name(s)

Metastatic cancer

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic cancer" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic cancer" returned 3777 free, full-text research articles on human participants. First 3 results:

Treatment of HER2-positive metastatic breast cancer.
 

Author(s): Sandra M Swain, Emma Clark, José Baselga

Journal: N. Engl. J. Med.. 2015 May;372(20):1964-5.

 

Last Updated: 14 May 2015

Go To URL
Validating of the pre-clinical mouse model for metastatic breast cancer to the mandible.
 

Author(s): Young Sun Hwang, Sang-Sun Han, Ki-Rim Kim, Lee Ye-Jin, Lee Sun-Kyung, Park Kwang-Kyun, Chung Won-Yoon

Journal: J Appl Oral Sci. ;23(1):3-8.

 

Metastatic breast carcinoma has a great tendency to spread to the mandible. It is concomitantly associated with bone destruction, food intake disorder, and a poorer prognosis. Appropriate animal models need to be developed for a better understanding of the mechanisms underlying the ...

Last Updated: 12 Mar 2015

Go To URL
Metastatic embryonal carcinoma mimicking locally advanced non-small cell lung cancer.
 

Author(s): Hiroki Numanami, Daisuke Takahashi, Emiko Takahashi, Eisuke Katsuda, Seiji Kamei, Katsuya Naruse, Kenji Baba, Masayuki Haniuda, Toyoharu Yokoi, Etsuro Yamaguchi, Akihito Kubo

Journal: Intern. Med.. 2015 ;54(1):59-61.

 

A 50-year-old man with a history of smoking of 45 pack-years underwent right lower lobectomy after neoadjuvant chemoradiotherapy for locally advanced non-small cell lung cancer diagnosed on a bronchial biopsy and standard imaging examinations, including chest-abdominal contrast-enhanced ...

Last Updated: 6 Mar 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic cancer" returned 383 free, full-text review articles on human participants. First 3 results:

Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer.
 

Author(s): Julie N Graff, Tomasz M Beer

Journal: Oncology (Williston Park, N.Y.). 2015 Jun;29(6):416-23.

 

Skeletal-related events contribute substantially to morbidity, mortality and cost in men with metastatic castration-resistant prostate cancer (mCRPC). There are five agents available for treatment in mCRPC that reduce skeletal-related events. Here we discuss the efficacy and safety ...

Last Updated: 20 Jun 2015

Go To URL
Targeted therapies for ER+/HER2- metastatic breast cancer.
 

Author(s): Mutsuko Yamamoto-Ibusuki, Monica Arnedos, Fabrice André

Journal:

 

The majority of breast cancers present with estrogen receptor (ER)-positive and human epidermal growth factor receptor (HER2)-negative features and might benefit from endocrine therapy. Although endocrine therapy has notably evolved during the last decades, the invariable appearance ...

Last Updated: 10 Jun 2015

Go To URL
[New therapeutical strategies in metastatic hormone-dependent breast cancer].
 

Author(s): Paul Vilquin, Pascale Cohen, Thierry Maudelonde, Olivier Tredan, Isabelle Treilleux, Thomas Bachelot, Pierre-Etienne Heudel

Journal: Bull Cancer. 2015 Apr;102(4):367-80.

 

Hormone-dependent breast cancer is the first example of cancer treated by targeted therapy for more than 30 years. Blocking estrogen pathway was the first therapeutical strategy for this subtype of breast cancer, and remains the principle of current standard treatment. Despite the ...

Last Updated: 13 Apr 2015

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Metastatic Melanoma; Renal Cancer

 

Last Updated: 3 Apr 2015

Go to URL
CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer
 

Status: Recruiting

Condition Summary: Metastatic Cancer; Pancreatic Cancer; Mesothelioma; Ovarian

 

Last Updated: 30 May 2015

Go to URL

Last Updated: 20 Apr 2015

Go to URL